FDA expert committee endorses Biogen Alzheimer's drug for full approval
A committee of expert advisors to the U.S. Food and Drug Administrator has endorsed an Alzheimer's disease drug made by Biogen Inc. and partner Eisai for full approval.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Rowan Walrath Source Type: news
More News: Alzheimer's | Health Management